Multiple Sclerosis News
News on Multiple Sclerosis continually updated from thousands of sources around the net.
6 hrs ago | CiteULike
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.
Are You as Liberal as President Obama?
Would you support legalizing marijuana in your state?
11 hrs ago | PhysOrg Weblog
New imaging research from Western University has demonstrated that a magnetic resonance imaging approach called quantitative susceptibility mapping can be an important tool for diagnosing and tracking the progression of Multiple Sclerosis and other neurological diseases.
15 hrs ago | BioSpace
Genzyme's Lemtradaa Approved in Australia for Treatment of Multiple Sclerosis CAMBRIDGE, Mass.-- -- Genzyme, a Sanofi company , announced today that the Australian Therapeutic Goods Administration has approved Lemtrada for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features ... (more)
20 hrs ago | The Miami Herald
"Over the next week, Josh will make a minor adjustment to his treatment protocol," Wild general manager Chuck Fletcher said.
An FDA advisory committee has recommended approval of alemtuzumab for the treatment of relapsing/remitting multiple sclerosis despite serious adverse effects and concerns of design bias in its clinical trials.
Massachusetts biotechs saw the U.S. approval of five drugs in the past year, including treatments for breast cancer, epilepsy and multiple sclerosis.
Multiple sclerosis , an inflammatory autoimmune disease affecting more than one million people worldwide, is caused by an immune reaction to myelin proteins, the proteins that help form the myelin insulating substance around nerves.
Opexa Therapeutics has been enrolling patients with secondary progressive multiple sclerosis for their study on Tcelna but Tuesday's reports show them having only 70% of the 180 needed enrollees.
Okay, I have written a LOT about the connection between wayward ERV activity and Multiple Sclerosis .
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis .
Oswego firefighter/paramedic David Sackett speaks to his attorney during a hearing before the Oswego Fire Protection District Board to determine whether he can stay in the position of fire inspector on Thursday, May 30, 2013, after a diagnosis of multiple sclerosis made it impossible for him to "work the streets" as a firefigther/paramedic.
The IPO has received strong support from existing international shareholders and new Australian institutional investors, with Patersons Securities Limited and Morgans Corporate Limited joint lead managers.
Opexa Therapeutics, Inc. , a biotechnology company developing TcelnaA , a patient-specific T-cell immunotherapy for the treatment of multiple sclerosis , is pleased to announce the enrollment of the 126th patient in the Phase IIb "Abili-T" clinical study of Tcelna in patients with Secondary Progressive Multiple Sclerosis .
Multiple sclerosis is one of those diseases that can slowly creep up on the body.
Copyright i 1 2 2013 Beacon Journal Publishing Co. Inc and Black Press. All Rights Reserved.